Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mouse models for mitochondrial disease.

D C Wallace1

  • 1Center for Molecular Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA. dwallace@gen.emory.edu

American Journal of Medical Genetics
|October 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutrition and its role in human evolution.

Journal of internal medicine·2019
Same author

Evidence for topologically protected surface states and a superconducting phase in [Tl4](Tl(1-x)Sn(x))Te3 using photoemission, specific heat, and magnetization measurements, and density functional theory.

Physical review letters·2014
Same author

Density of states features in some anomalous melting elements.

Journal of physics. Condensed matter : an Institute of Physics journal·2013
Same author

Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan.

Oncogene·2012
Same author

Bioenergetic origins of complexity and disease.

Cold Spring Harbor symposia on quantitative biology·2011
Same author

Mitochondria, bioenergetics, and the epigenome in eukaryotic and human evolution.

Cold Spring Harbor symposia on quantitative biology·2009

Mitochondrial gene mutations cause various neuromuscular diseases. Mouse models reveal how these mutations lead to conditions like myopathy, cardiomyopathy, and diabetes, highlighting the role of reactive oxygen species in disease and aging.

Area of Science:

  • Mitochondrial genetics and disease pathogenesis.
  • Genetics, molecular biology, and pathophysiology of neuromuscular disorders.

Background:

  • Mutations in both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) genes are linked to diverse neuromuscular diseases.
  • These mutations disrupt essential mitochondrial functions like oxidative phosphorylation and nucleic acid metabolism, leading to conditions such as myopathy, cardiomyopathy, and Leigh syndrome.

Purpose of the Study:

  • To investigate the functional consequences of specific mitochondrial gene mutations using mouse models.
  • To elucidate the role of mitochondrial dysfunction and reactive oxygen species (ROS) in the development of various diseases and aging.

Main Methods:

  • Generation of mouse models with specific mtDNA mutations (e.g., CAP resistance, deletions) and nDNA gene disruptions (e.g., Tfam, Ant1, Ucp, Gpx1, Sod2).

Related Experiment Videos

  • Analysis of resulting phenotypes including myopathy, cardiomyopathy, cataracts, diabetes, and accelerated aging.
  • Investigation of mitochondrial parameters such as oxidative phosphorylation, ATP/ADP ratio, mitochondrial membrane potential (Delta Psi), and ROS production.
  • Treatment of affected mouse models and C. elegans with catalytic antioxidant drugs.

    • Main Results:

    • Mitochondrial gene mutations in mice recapitulated human diseases, causing myopathy, cardiomyopathy, cataracts, and diabetes.
    • Inactivation of Tfam led to neonatal lethal cardiomyopathy and diabetes.
    • Ant1 gene inactivation resulted in myopathy, cardiomyopathy, multiple mtDNA deletions, and increased ROS.
    • Inactivation of Ucp proteins demonstrated the regulation of ROS by mitochondrial membrane potential.
    • Inactivation of Gpx1 and Sod2 confirmed the role of mitochondrial ROS toxicity in growth retardation, dilated cardiomyopathy, and accelerated aging.

    Conclusions:

    • Mouse models are valuable tools for studying mitochondrial diseases and their underlying mechanisms.
    • Mitochondrial dysfunction and ROS production are critical contributors to a spectrum of diseases and the aging process.
    • Targeting ROS with antioxidant drugs shows potential for mitigating mitochondrial disease and age-related decline.